Newsletter Archive

1. 09.19.18 -- Manual Aseptic Processing: The Last Resort Or The Best Approach?
   9/19/2018
   09/19/18 BioProcess Online Newsletter
2. 09.18.18 -- Strategic Considerations In Drug Development
   9/18/2018
   09/18/18 BioProcess Online Newsletter
3. 09.17.18 -- Education vs. Experience: What's More Important In Biopharma Operations?
   9/17/2018
   09/17/18 BioProcess Online Newsletter
4. 09.12.18 -- Brexit: The Good, The Bad, And The Chaos
   9/12/2018
   09/12/18 BioProcess Online Newsletter
5. 09.11.18 -- Automation Drives Flexibility And Efficiency For Fujifilm Diosynth Biotechnologies
   9/11/2018
   09/11/18 BioProcess Online Newsletter
6. 09.10.18 -- FDA And Quality Metrics: Where Do Things (Currently) Stand?
   9/10/2018
   09/10/18 BioProcess Online Newsletter
7. 09.05.18 -- Is Obsolescence The Best Biosimilar Defense?
   9/5/2018
   09/05/18 BioProcess Online Newsletter
8. 08.29.18 -- 9 Challenges Keeping Cell And Gene Therapy Executives Up At Night
   8/29/2018
   08/29/18 BioProcess Online Newsletter
9. 08.27.18 -- A 6-Step Process To Assess Risk And Benefit In ICH Q9 Decision Making
   8/27/2018
   08/27/18 BioProcess Online Newsletter
10. 08.22.18 -- FDA's New Guidance On Replication Competent Retrovirus Testing During Gene Therapy Manufacture
    8/22/2018
    08/22/18 BioProcess Online Newsletter